Thromb Haemost 2014; 111(06): 1187-1190
DOI: 10.1160/TH13-08-0642
Letters to the Editor
Schattauer GmbH

Unravelling the Smokers’ Paradox: Cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y12 inhibitors

Paul A. Gurbel
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Brian A. Baker
2   Daiichi Sankyo, Inc., Parsippany, New Jersey, USA
,
William L. Bailey
2   Daiichi Sankyo, Inc., Parsippany, New Jersey, USA
,
Kevin P. Bliden
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Udaya S. Tantry
1   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
› Author Affiliations
Further Information

Publication History

Received: 05 August 2013

Accepted after major revision: 05 January 2014

Publication Date:
02 December 2017 (online)

Preview